MX2011011687A - Flavonas sustituidas de pirrolidina como sensibilizadores de radio para su uso en el tratamiento del cancer. - Google Patents
Flavonas sustituidas de pirrolidina como sensibilizadores de radio para su uso en el tratamiento del cancer.Info
- Publication number
- MX2011011687A MX2011011687A MX2011011687A MX2011011687A MX2011011687A MX 2011011687 A MX2011011687 A MX 2011011687A MX 2011011687 A MX2011011687 A MX 2011011687A MX 2011011687 A MX2011011687 A MX 2011011687A MX 2011011687 A MX2011011687 A MX 2011011687A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- cancer
- combination
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1174MU2009 | 2009-05-05 | ||
US22452409P | 2009-07-10 | 2009-07-10 | |
PCT/IB2010/051921 WO2010128443A1 (en) | 2009-05-05 | 2010-05-03 | Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011011687A true MX2011011687A (es) | 2012-02-29 |
Family
ID=42352216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011011687A MX2011011687A (es) | 2009-05-05 | 2010-05-03 | Flavonas sustituidas de pirrolidina como sensibilizadores de radio para su uso en el tratamiento del cancer. |
Country Status (14)
Country | Link |
---|---|
US (1) | US8895605B2 (zh) |
EP (1) | EP2427188B1 (zh) |
JP (1) | JP5730288B2 (zh) |
KR (1) | KR20120032476A (zh) |
CN (1) | CN102458398B (zh) |
AR (1) | AR079092A1 (zh) |
AU (1) | AU2010244101A1 (zh) |
CA (1) | CA2761182A1 (zh) |
IL (1) | IL216163A0 (zh) |
MX (1) | MX2011011687A (zh) |
NZ (1) | NZ596861A (zh) |
RU (1) | RU2011148954A (zh) |
TW (1) | TWI461194B (zh) |
WO (1) | WO2010128443A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201242597A (en) * | 2011-03-14 | 2012-11-01 | Piramal Life Sciences Ltd | A synergistic pharmaceutical combination for the treatment of pancreatic cancer |
TW201300105A (zh) * | 2011-05-31 | 2013-01-01 | Piramal Life Sciences Ltd | 治療頭頸鱗狀細胞癌之相乘藥物組合物 |
MX2013014950A (es) | 2011-06-24 | 2014-04-16 | Piramal Entpr Ltd | Compuestos para el tratamiento del cancer asociado con el papilomavirus humano. |
WO2013105056A1 (en) * | 2012-01-13 | 2013-07-18 | Piramal Enterprises Limited | Pyrrolidine- substituted flavone derivatives for prevention or treatment of oral mucositis |
CA3163776A1 (en) | 2012-08-03 | 2014-02-06 | Foundation Medicine, Inc. | Human papilloma virus as predictor of cancer prognosis |
TWI680760B (zh) | 2013-07-12 | 2020-01-01 | 印度商皮拉馬爾企業有限公司 | 治療黑色素瘤的藥物組合 |
CN114478524A (zh) * | 2022-03-15 | 2022-05-13 | 江苏省肿瘤医院 | 1,8-萘啶类化合物及其应用 |
CN114560799A (zh) * | 2022-03-15 | 2022-05-31 | 江苏省肿瘤医院 | 腈基取代苯基类化合物及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN164232B (zh) | 1986-04-11 | 1989-02-04 | Hoechst India | |
US6281223B1 (en) * | 1999-04-13 | 2001-08-28 | Supergen, Inc. | Radioenhanced camptothecin derivative cancer treatments |
TWI331034B (en) | 2002-07-08 | 2010-10-01 | Piramal Life Sciences Ltd | Inhibitors of cyclin-dependent kinases and their use |
US7272193B2 (en) | 2003-06-30 | 2007-09-18 | Intel Corporation | Re-mapping trellis encoded data associated with a 2-bit constellation tone to data associated with a pair of 1-bit constellation tones |
DK2046738T3 (da) * | 2006-06-21 | 2014-08-04 | Piramal Entpr Ltd | Enantiomerisk rene flavonderivativer til behandlingen af proliferative lidelser, samt processer til deres tilberedelse |
PT2041121E (pt) | 2006-07-07 | 2011-09-12 | Piramal Life Sciences Ltd | Síntese enantiosselectiva de pirrolidinas substituídas com flavonas |
WO2008139271A2 (en) | 2007-05-15 | 2008-11-20 | Piramal Life Sciences Limited | A synergistic pharmaceutical combination for the treatment of cancer |
-
2010
- 2010-04-19 TW TW099112188A patent/TWI461194B/zh not_active IP Right Cessation
- 2010-05-03 AU AU2010244101A patent/AU2010244101A1/en not_active Abandoned
- 2010-05-03 NZ NZ596861A patent/NZ596861A/en unknown
- 2010-05-03 MX MX2011011687A patent/MX2011011687A/es active IP Right Grant
- 2010-05-03 CA CA2761182A patent/CA2761182A1/en not_active Abandoned
- 2010-05-03 CN CN201080027763.5A patent/CN102458398B/zh active Active
- 2010-05-03 KR KR1020117029101A patent/KR20120032476A/ko not_active Application Discontinuation
- 2010-05-03 US US13/318,235 patent/US8895605B2/en active Active
- 2010-05-03 WO PCT/IB2010/051921 patent/WO2010128443A1/en active Application Filing
- 2010-05-03 RU RU2011148954/15A patent/RU2011148954A/ru unknown
- 2010-05-03 EP EP10724898.1A patent/EP2427188B1/en active Active
- 2010-05-03 JP JP2012509135A patent/JP5730288B2/ja active Active
- 2010-05-04 AR ARP100101501A patent/AR079092A1/es not_active Application Discontinuation
-
2011
- 2011-11-06 IL IL216163A patent/IL216163A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US8895605B2 (en) | 2014-11-25 |
IL216163A0 (en) | 2012-01-31 |
WO2010128443A1 (en) | 2010-11-11 |
RU2011148954A (ru) | 2013-06-10 |
JP2012526098A (ja) | 2012-10-25 |
EP2427188A1 (en) | 2012-03-14 |
NZ596861A (en) | 2014-01-31 |
CA2761182A1 (en) | 2010-11-11 |
EP2427188B1 (en) | 2016-08-10 |
KR20120032476A (ko) | 2012-04-05 |
AU2010244101A1 (en) | 2012-01-12 |
AR079092A1 (es) | 2011-12-28 |
AU2010244101A2 (en) | 2011-12-22 |
TW201039817A (en) | 2010-11-16 |
US20120046334A1 (en) | 2012-02-23 |
CN102458398B (zh) | 2014-07-16 |
JP5730288B2 (ja) | 2015-06-10 |
CN102458398A (zh) | 2012-05-16 |
TWI461194B (zh) | 2014-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011011687A (es) | Flavonas sustituidas de pirrolidina como sensibilizadores de radio para su uso en el tratamiento del cancer. | |
MY150797A (en) | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer | |
MX2011009796A (es) | Inhibidores de la cinasa pi3. | |
MY150697A (en) | Methods of treating cancer using pyridopyrimdinone inhibitors of p13k alpha | |
MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
MX2011011335A (es) | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina. | |
TN2012000622A1 (en) | Combinations of kinase inhibitors for the treatment of cancer | |
CR11510A (es) | Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer | |
CA2909625C (en) | Combination therapy comprising a tor kinase inhibitor and a 5-substituted quinazolinone compound for treating cancer | |
SG10201810401RA (en) | Pharmaceutical combinations for treating cancer | |
MX2014002171A (es) | Tratamientos de combinacion para hepatitis c. | |
TN2011000298A1 (en) | Compounds useful for inhibiting chk1 | |
CA2908742C (en) | Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer | |
WO2015095834A3 (en) | Cancer treatments using erk1/2 and bcl-2 family inhibitors | |
PH12016502353A1 (en) | Pharmaceutical composition | |
TW201613577A (en) | Pharmaceutical combinations | |
MX2017012123A (es) | Combinaciones de un compuesto inhibidor de fosfoinositido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cancer. | |
MX2010004967A (es) | Uso de inhibidor de cfms para el tratamiento y la prevención del cancer de hueso, así como la perdida osea y el dolor de hueso asociados con el cancer de hueso. | |
PH12020500099A1 (en) | Therapeutic combination of a third generation egfr tyrosine kinase inhibitor and a cyclin d kinase inhibitor | |
WO2015035410A8 (en) | Cancer therapy | |
WO2007081572A3 (en) | Inhibitors of checkpoint kinases | |
WO2006074281A3 (en) | Inhibitors of checkpoint kinases | |
WO2007136615A3 (en) | Combination cancer therapy | |
MX2008016520A (es) | Medicamentos. | |
WO2006074207A3 (en) | Inhibitors of checkpoint kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: PIRAMAL ENTERPRISES LIMITED.* |
|
HC | Change of company name or juridical status |
Owner name: PIRAMAL ENTERPRISES LIMITED.* |
|
FG | Grant or registration |